SK Chemicals will jointly carry out development and Phase 3 clinical trial of next generation children enteritis vaccine

SK Chemicals is enlarging its position in the international market with its technology and manufacturing power in vaccine.

SK Chemicals announced on the 1^st that it signed an agreement for development of a next-generation enteritis vaccines for children with the PATH(Program for Appropriate Technology in Health), an international non-profit organization. The purpose of the agreement is to supp...